Submission for OMB Review; 30-Day Comment Request; Intramural Continuing Umbrella of Research Experiences (iCURE) Application-National Cancer Institute, 51965-51966 [2018-22319]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 199 / Monday, October 15, 2018 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Cardiovascular Sciences.
Date: November 8–9, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Alexandria Old
Town, 1900 Diagonal Road, Alexandria, VA
22314.
Contact Person: Margaret Chandler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4126,
MSC 7814, Bethesda, MD 20892, (301) 435–
1743, margaret.chandler@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Myalgic
Encephalomyelitis/Chronic Fatigue
Syndrome.
Date: November 8, 2018.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Jana Drgonova, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5213,
Bethesda, MD 20892, 301–827–2549,
jdrgonova@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Prevention.
Date: November 8, 2018.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Syed M. Quadri, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6210,
MSC 7804, Bethesda, MD 20892, 301–435–
1211, quadris@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 9, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–22318 Filed 10–12–18; 8:45 am]
khammond on DSK30JT082PROD with NOTICES
BILLING CODE 4140–01–P
VerDate Sep<11>2014
21:34 Oct 12, 2018
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Intramural
Continuing Umbrella of Research
Experiences (iCURE) Application—
National Cancer Institute
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
ADDRESSES: Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, should be
directed to the: Office of Management
and Budget, Office of Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: Desk
Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Alison Lin, 9609
Medical Center Drive, Rockville, MD
20850 or call non-toll-free number (240)
276–6177 or Email your request,
including your address to: linaj@
mail.nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on July 27, 2018, page 35665
(83 FR 35665) and allowed 60 days for
public comment. No public comments
were received. The purpose of this
notice is to allow an additional 30 days
for public comment.
The National Cancer Institute (NCI),
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
SUMMARY:
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
51965
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Intramural
Continuing Umbrella of Research
Experiences (iCURE) Application, 0925–
XXXX, Exp., Date XX/XXXX, EXISTING
COLLECTION IN USE WITHOUT OMB
NUMBER, National Cancer Institute
(NCI), National Institutes of Health
(NIH).
Need and Use of Information
Collection: The new Intramural
Continuing Umbrella of Research
Experiences (iCURE) program supports
mentored research experiences for
qualified post-baccalaureate (including
post masters) individuals, graduate
students, and postdoctoral fellows in
the multidisciplinary National Cancer
Institute (NCI) intramural research
environment. This information
collection request are applications and a
reference letter to help evaluate the
merits of the candidates and their
potential match for the iCURE program.
iCURE is an extension of the highly
successful NCI Center to Reduce Cancer
Health Disparities’ (CRCHD) Continuing
Umbrella of Research Experiences
(CURE) program which helps support
the career progress of its scholars
toward research independence, as well
as fosters and sustains diversity in the
biomedical research pipeline. Like the
CURE program, iCURE strongly
encourages the participation of
individuals from underrepresented
populations and is aligned with NCI’s
interest in diversity. The benefit of
collecting this information is to enable
the selection of the best matching
candidates for the iCURE program. The
iCURE program aims to, 1. Enhance the
diversity of the NCI Intramural Research
Program (IRP), and 2. Promote the career
progress of the iCURE scholars in cancer
research.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated burden hours are 305.
E:\FR\FM\15OCN1.SGM
15OCN1
51966
Federal Register / Vol. 83, No. 199 / Monday, October 15, 2018 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Post-Baccalaureate
Supplemental
Application.
Graduate Student Application ...........
Postdoctoral Fellowship Application
Reference Letter ...............................
Post-Baccalaureate (Including PostMaster’s) Individuals.
Graduate Students ...........................
Postdoctoral Candidates ..................
PIs, professors, supervisors .............
50
1
30/60
25
30
50
240
1
1
1
2
2
30/60
60
100
120
Totals .........................................
...........................................................
370
370
........................
305
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 5, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–22319 Filed 10–12–18; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2018–22311 Filed 10–12–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSK30JT082PROD with NOTICES
Average
time per
response
(in hours)
Type of
respondent
Dated: October 2, 2018.
Patricia M. Busche,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.
Number of
respondents
Number of
responses
per
respondent
Form name
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Genomic Centers for
Infectious Diseases (U19 Clinical Trial Not
Allowed).
Date: November 8–9, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Eleazar Cohen, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G62A, National Institute of Health,
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20899823, (240) 669–5081,
ecohen@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
VerDate Sep<11>2014
21:34 Oct 12, 2018
Jkt 247001
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: November 5, 2018.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Lee G. Klinkenberg, Ph.D.,
Scientific Review Program, DEA/NIAID/NIH/
DHHS, 5601 Fishers Lane, MSC–9823,
Bethesda, MD 20892–9834, 301–761–7749,
lee.klinkenberg@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Sexually Transmitted
Infections CRC: Vaccine Development (U19).
Date: November 8–9, 2018.
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Total annual
burden hour
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Annie Walker-Abbey,
Ph.D., Scientific Review Officer, Scientific
Review Program, AID/NIH/DHHS, 5601
Fishers Lane, Room 3E70A, Rockville, MD
20852, 240–627–3390, aabbey@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 5, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–22312 Filed 10–12–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIH
Pathway to Independence Award (K99/R00).
Date: October 17, 2018.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\15OCN1.SGM
15OCN1
]]>Agencies
[Federal Register Volume 83, Number 199 (Monday, October 15, 2018)]
[Notices]
[Pages 51965-51966]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-22319]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request; Intramural
Continuing Umbrella of Research Experiences (iCURE) Application--
National Cancer Institute
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30-days of the date of
this publication.
ADDRESSES: Written comments and/or suggestions regarding the item(s)
contained in this notice, especially regarding the estimated public
burden and associated response time, should be directed to the: Office
of Management and Budget, Office of Regulatory Affairs,
[email protected] or by fax to 202-395-6974, Attention: Desk
Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Alison Lin, 9609 Medical Center Drive, Rockville,
MD 20850 or call non-toll-free number (240) 276-6177 or Email your
request, including your address to: [email protected].
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on July 27, 2018, page
35665 (83 FR 35665) and allowed 60 days for public comment. No public
comments were received. The purpose of this notice is to allow an
additional 30 days for public comment.
The National Cancer Institute (NCI), National Institutes of Health,
may not conduct or sponsor, and the respondent is not required to
respond to, an information collection that has been extended, revised,
or implemented on or after October 1, 1995, unless it displays a
currently valid OMB control number.
In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, the National Institutes of Health (NIH) has submitted to
the Office of Management and Budget (OMB) a request for review and
approval of the information collection listed below.
Proposed Collection: Intramural Continuing Umbrella of Research
Experiences (iCURE) Application, 0925-XXXX, Exp., Date XX/XXXX,
EXISTING COLLECTION IN USE WITHOUT OMB NUMBER, National Cancer
Institute (NCI), National Institutes of Health (NIH).
Need and Use of Information Collection: The new Intramural
Continuing Umbrella of Research Experiences (iCURE) program supports
mentored research experiences for qualified post-baccalaureate
(including post masters) individuals, graduate students, and
postdoctoral fellows in the multidisciplinary National Cancer Institute
(NCI) intramural research environment. This information collection
request are applications and a reference letter to help evaluate the
merits of the candidates and their potential match for the iCURE
program. iCURE is an extension of the highly successful NCI Center to
Reduce Cancer Health Disparities' (CRCHD) Continuing Umbrella of
Research Experiences (CURE) program which helps support the career
progress of its scholars toward research independence, as well as
fosters and sustains diversity in the biomedical research pipeline.
Like the CURE program, iCURE strongly encourages the participation of
individuals from underrepresented populations and is aligned with NCI's
interest in diversity. The benefit of collecting this information is to
enable the selection of the best matching candidates for the iCURE
program. The iCURE program aims to, 1. Enhance the diversity of the NCI
Intramural Research Program (IRP), and 2. Promote the career progress
of the iCURE scholars in cancer research.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated burden hours are
305.
[[Page 51966]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Form name Type of Number of responses per per response Total annual
respondent respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
Post-Baccalaureate Post- 50 1 30/60 25
Supplemental Application. Baccalaureate
(Including Post-
Master's)
Individuals.
Graduate Student Application.. Graduate 30 1 2 60
Students.
Postdoctoral Fellowship Postdoctoral 50 1 2 100
Application. Candidates.
Reference Letter.............. PIs, professors, 240 1 30/60 120
supervisors.
---------------------------------------------------------------
Totals.................... ................ 370 370 .............. 305
----------------------------------------------------------------------------------------------------------------
Dated: October 2, 2018.
Patricia M. Busche,
Project Clearance Liaison, National Cancer Institute, National
Institutes of Health.
[FR Doc. 2018-22319 Filed 10-12-18; 8:45 am]
BILLING CODE 4140-01-P
